Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a pill and stock chart

Jun 2, 2026

A Look At Recursion Pharmaceuticals (RXRX) Valuation As Shares Show Short Term Momentum

Recursion Pharmaceuticals (RXRX) is experiencing renewed investor interest, closing recently at $3.79. Despite a significant revenue of $66.41 million, the company reported a net loss of $559.78 million, leading to a market valuation of approximately $1.91 billion. The stock has shown short-term momentum with a 25.91% increase over the past week and an 11.80% rise over the last month, contrasting with a year-to-date decline of 9.76%.Current market sentiment suggests that RXRX is perceived as ove
A mass spectrometer in a laboratory setting

Jun 2, 2026

What Danaher (DHR)'s New AI-Enabled SCIEX Mass Spec Platform Means For Shareholders

Danaher’s recent upgrades to its SCIEX mass spectrometry platform signal a strategic move towards enhancing its market position in life sciences through AI integration.SCIEX, a subsidiary of Danaher, has introduced significant enhancements to its ZenoTOF line and launched the novus V55 triple quadrupole mass spectrometer, both powered by the new AI-enabled SCIEX OS 5.0 software. These advancements aim to optimize complex laboratory workflows and improve sensitivity, thereby bolstering Danaher's
A minimalist illustration of a microbe and abstract cells in a dark palette.

Jun 2, 2026

Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference

Zealand Pharma is set to engage in discussions at the upcoming Goldman Sachs Global Healthcare Conference, highlighting its commitment to advancing metabolic health solutions.On June 9, 2026, Adam Steensberg, the CEO of Zealand Pharma, will participate in a fireside chat during the 47th Annual Global Healthcare Conference in Miami. This event will be accessible via a live audio webcast, allowing stakeholders to tune in and gain insights into the company's strategic direction and innovations in m
A minimalist illustration of a pill against a solid background.

Jun 2, 2026

Life Sciences Outlook: Growth Strategies in 2026

The life sciences sector is approaching 2026 with a focus on technology transformation, particularly through artificial intelligence (AI), as highlighted in the C-Suite Barometer from Forvis Mazars. Despite optimism among executives, challenges such as increased competition and supply chain constraints loom large.The report indicates that 92% of life sciences leaders maintain a positive outlook for their organizations, even as revenue growth showed a slight decline in 2025. Key obstacles include
A minimalist illustration of a magnifying glass symbolizing epidemiological research.

Jun 2, 2026

Briya Appoints Professor Jonathan M. Samet As Chief Epidemiologist To Strengthen AI-Driven Clinical Research

Briya, a healthtech AI company, has appointed Professor Jonathan M. Samet as Chief Epidemiologist to enhance its AI-driven clinical research capabilities. This strategic move aims to integrate robust epidemiological methodologies into Briya’s AIRE research engine, ensuring that AI can generate credible evidence for medical studies.The integration of epidemiology is pivotal for Briya’s mission to refine AI from a general tool into a specialized research system. By embedding medical reasoning and
A training manual on an office desk in a dimly lit setting

Jun 2, 2026

Infosecurity Europe: Bayer Reinvents Security Awareness Training to Counter AI Threats

Bayer is transforming its security awareness training to better address AI-driven threats in the pharmaceutical sector, as highlighted by Kevin Jones, the company's Chief Information Security Officer (CISO), at Infosecurity Europe 2026.In a significant shift, Bayer has moved away from traditional technical training methods, which often focused on identifying basic red flags like spelling errors or suspicious links. Jones emphasized that these tactics have become obsolete due to sophisticated AI-
A laboratory workspace with labeling materials scattered on a table, illustrating the process of artwork and labeling in life sciences.

Jun 2, 2026

AI and Automation in Artwork & Labelling for Life Sciences: Advancing Quality and Efficiency, Upcoming Webinar Hosted by Xtalks

A forthcoming webinar will delve into how AI and automation are transforming labeling and artwork processes in the life sciences sector, aiming to enhance quality and efficiency.The event will explore the persistent issue of labeling errors, a significant contributor to pharmaceutical recalls. As regulatory demands intensify, the focus is shifting from merely identifying errors to preventing them earlier in the workflow. Featured speakers will discuss implementing AI-driven quality checks that o
A minimalist illustration of a pill and tablet on a solid background.

Jun 2, 2026

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

BullFrog AI has announced the formation of a new commercial leadership team aimed at accelerating growth for its integrated pharmaceutical AI platform.The newly appointed team consists of seasoned executives with extensive backgrounds in enterprise IT solutions, drug discovery, and advanced therapy platforms. Their collective expertise is expected to enhance BullFrog AI's commercial strategy and expand its pipeline for AI-driven solutions, including products like bfPREP, bfLEAP, and bfARENAS. Th
3D mapping system in a clinical setting

Jun 2, 2026

Rhythm AI Appoints Medtech Veteran Mike Dineen as Chief Executive Officer

Rhythm AI has appointed Mike Dineen as its new CEO, aiming to enhance its commercial presence in the atrial fibrillation (AF) treatment space.With over three decades of experience in the MedTech sector, Dineen is set to lead Rhythm AI through a critical phase of U.S. clinical and commercial expansion. He joins the company following the recent FDA 510(k) clearance of its STAR Apollo Mapping System, which integrates with leading 3D mapping platforms. This compatibility is expected to facilitate a
A minimalist illustration of a flashcard and an open book against a dark background, representing educational tools.

Jun 2, 2026

AI tutor supports student learning

A new AI tutor developed at Iowa State University aims to enhance student learning by providing on-demand educational support.Assistant Professor Karl Kerns has spent two years creating this innovative tool alongside his graduate students, designed to supplement traditional classroom instruction in the Domestic Animal Anatomy and Physiology Lab. The AI tutor allows students to engage with course material at their convenience, offering features such as flashcard creation and guided practice sessi
A stethoscope and heart model in a clinical setting

Jun 2, 2026

IRTC: Strong growth, AI innovation, and global expansion drive leadership in cardiac diagnostics

The recent conference for iRhythm Holdings, Inc. (IRTC) showcased significant advancements in cardiac diagnostics, underscoring the company's strong revenue growth and increasing market presence.Key highlights included impressive financial performance and a focus on AI-driven innovations that enhance cardiac monitoring capabilities. The company's strategic initiatives aim to penetrate primary care markets and explore new diagnostic pathways, positioning IRTC favorably for future growth.Additiona
A minimalist representation of a blood droplet and an immune cell silhouette.

Jun 2, 2026

London biotech raises $53M to decode the immune system using a single blood sample

IMU Biosciences has successfully raised over $53 million in an extended Series A funding round, aimed at revolutionizing immune system analysis through advanced technology.The London-based biotech firm, co-led by IQ Capital and Molten Ventures, has developed the largest immune dataset in the world, encompassing over 25,000 individuals and generating more than 100 million immune data points from a single blood sample. This innovative approach addresses a significant gap in precision medicine, whe